Abstract

PrimPol is a recently identified polymerase involved in eukaryotic DNA damage tolerance, employed in both re-priming and translesion synthesis mechanisms to bypass nuclear and mitochondrial DNA lesions. In this report, we investigate how the enzymatic activities of human PrimPol are regulated. We show that, unlike other TLS polymerases, PrimPol is not stimulated by PCNA and does not interact with it in vivo. We identify that PrimPol interacts with both of the major single-strand binding proteins, RPA and mtSSB in vivo. Using NMR spectroscopy, we characterize the domains responsible for the PrimPol-RPA interaction, revealing that PrimPol binds directly to the N-terminal domain of RPA70. In contrast to the established role of SSBs in stimulating replicative polymerases, we find that SSBs significantly limit the primase and polymerase activities of PrimPol. To identify the requirement for this regulation, we employed two forward mutation assays to characterize PrimPol's replication fidelity. We find that PrimPol is a mutagenic polymerase, with a unique error specificity that is highly biased towards insertion-deletion errors. Given the error-prone disposition of PrimPol, we propose a mechanism whereby SSBs greatly restrict the contribution of this enzyme to DNA replication at stalled forks, thus reducing the mutagenic potential of PrimPol during genome replication.

Highlights

  • Accurate and efficient DNA replication is essential for the maintenance of genomic integrity

  • In vitro studies have shown that the ability of Pol ␩ and REV1 to bypass an abasic site is stimulated by the presence of mono-ubiquitinated proliferating cell nuclear antigen (PCNA) over unmodified PCNA

  • These results demonstrate that PrimPol, unlike other translesion DNA synthesis (TLS) polymerases, is not stimulated by either unmodified or mono-ubiquitinated PCNA, suggesting that the enzyme is regulated by another distinct mechanism

Read more

Summary

Introduction

Accurate and efficient DNA replication is essential for the maintenance of genomic integrity. The replication machinery is a highly specialized multi-protein complex employed for this purpose, with the replicative DNA polymerases (Pols), Pol ␣, Pol ␦ and Pol ⑀, tasked with the majority of bulk DNA synthesis in the eukaryotic nucleus. In mitochondria, this task is undertaken by Pol␥. Helix-distorting DNA lesions and structures, which persist into the S-phase of the cell cycle, present an obstacle to the replicative polymerases, causing stalling of the replication fork [1]. Cells employ a variety of DNA damage tolerance mechanisms to facilitate lesion/structure bypass and permit continued replication [2,3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call